UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

KARAKTERISTIK AUTOIMUNISASI PADA PASIEN TALASEMIA YANG MENDAPAT TRANSFUSI BERULANG DENGAN HASIL COOMB’S TEST POSITIF

dc.contributor.authorPopy, Florentina
dc.date.accessioned2026-09-24T17:59:19Z
dc.date.issued2024-02-15
dc.descriptionDr. dr. Zelly Dia Rofinda, Sp.PK, Subsp.B.D.K.T.(K), Subsp.H.K.(K)
dc.description.abstractLatar Belakang: Pasien talasemia membutuhkan transfusi berulang untuk kelangsungan hidupnya, sehingga risiko aloimunisasi dan autoimunisasi meningkat. Aloimunisasi dan autoimunisasi pada talasemia dapat menyebabkan kesulitan dalam menemukan darah yang cocok untuk transfusi dan dapat menyebabkan reaksi transfusi hemolitik. Diagnosis dini adanya aloimunisasi dan autoimunisasi mampu meningkatkan efektifitas pemberian transfusi pada pasien talasemia. Coomb’s test digunakan untuk mendeteksi adanya aloimunisasi dan autoimunisasi. Penelitian ini bertujuan untuk mengetahui karakteristik aloimunisasi dan autoimunisasi pada pasien talasemia yang mendapat transfusi berulang dengan hasil Coomb’s test positif. Metode: Penelitian ini merupakan penelitian deskriptif dengan rancangan potong lintang terhadap 35 pasien talasemia yang mendapat transfusi berulang dengan hasil Coomb’s test positif di RSUP Dr. M. Djamil Padang pada bulan April 2023 sampai Desember 2023. Pasien talasemia yang didiagnosis oleh klinisi dengan transfusi minimal dua unit peckred cell (PRC) akan dilakukan pemeriksaan Coomb’s test dengan metode gel agglutination untuk menilai adanya aloimunisasi dan autoimunisasi. Hasil indirect Coomb’s test positif dinyatakan sebagai aloimunisasi, hasil direct Coomb’s test positif atau direct dan indirect Coomb’s test positif dinyatakan sebagai autoimunisasi. Hasil: Pasien talasemia yang mendapat transfusi berulang dengan hasil Coomb’s test positif di RSUP Dr. M. Djamil Padang yang mengalami autoimunisasi ditemukan sebanyak 35 (100%), sedangkan subjek penelitian yang mengalami aloimunisasi tidak ditemukan (0%). Pasien talasemia yang mendapat transfusi berulang dengan autoimunisasi memiliki karakteristik yaitu terbanyak pada perempuan yaitu 21 (60%) pasien, umur terbanyak 0-18 tahun yaitu 24 (68,6%) pasien, semua didiagnosis talasemiaβ mayor (100%), golongan darah terbanyak O yaitu 14 (40%) pasien, rhesus positif (100%), frekuensi transfusi 2 kali per bulan (100%), lama waktu mendapat transfusi terbanyak selama >10 tahun yaitu 26 (74,3%) pasien, subjek penelitian yang tidak menjalani splenektomi yaitu 34 (97,1%) pasien dan derajat aglutinasi terbanyak derajat 1+ yaitu 27 (77,2%) pasien. Antibodi terbanyak yang menyelimuti eritrosit pada pasien talasemia yang mendapat transfusi berulang dengan autoimunisasi yaitu IgG sebanyak 34 (97,1%) pasien. Simpulan: Pasien talasemia yang mendapat transfusi berulang dengan hasil Coomb’s test positif di RSUP Dr. M. Djamil Padang semuanya mengalami autoimunisasi dengan karakteristik terbanyak pada perempuan, umur 0-18 tahun, semua didiagnosis talasemia β mayor, golongan darah terbanyak O, rhesus positif, frekuensi transfusi 2 kali per bulan, lama waktu mendapat transfusi terbanyak selama >10 tahun, terbanyak tidak menjalani splenektomi dan derajat aglutinasi terbanyak derajat 1+. Antibodi yang menyelimuti eritrosit pada pasien talasemia yang mendapat transfusi berulang dengan autoimunisasi di RSUP Dr. M. Djamil Padang yaitu IgG.
dc.identifier.urihttps://ailib.my.id/handle/123456789/9002
dc.language.isoid
dc.publisherUniversitas Andalas
dc.subjectKata kunci: aloimunisasi
dc.subjectautoimunisasi
dc.subjecttalasemia
dc.subjecttransfusi darah berulang
dc.subjecthasil
dc.subjectCoomb’s test positif
dc.subject.classificationR Medicine (General)
dc.titleKARAKTERISTIK AUTOIMUNISASI PADA PASIEN TALASEMIA YANG MENDAPAT TRANSFUSI BERULANG DENGAN HASIL COOMB’S TEST POSITIF
dc.typeThesis
dcterms.dateSubmitted2024-02-29
dcterms.referencesAl-Riyami AZ & Daar S. 2019. Red cell alloimmunization in transfusion-dependent and transfusion-independent beta thalassemia: A review from the Eastern Mediterranean Region (EMRO). Transfusion and Apheresis Science, 58(6), 102678. Angastiniotis M & Lobitz S. 2019. ‘Talasemia: An Overview.’ In: Int. J. Neonatal Screen, 5(16), p 1-11. https:doi.org/10.3390/ijns5010016 Barcellini W, Giannotta JA, and Fattizzo B. 2021. Autoimmune Complication in Hematologic Neoplasm in Cancers. No. 13. Vol. 1532. P: 1-9. Barnes BC. 2015. Blood Bank Applications of Antigen–Antibody Reactions in Clinical Laboratory Blood Banking and Transfusion Medicine Principles and Practices. First Edition. Editor: Johns GS, Blessing EAG, Zundel B and Denesiuk L. New Jersey:Pearson Education. P(3): 39-51. Bhuva DK, Vachhani JH. 2017. Red cell alloimmunization in repeatedly transfused patients. Asian Journal of Transfusion Science (11). p:115-20. Brancaleoni V, Pierro E, Motta I, Cappelini MD. 2016. Laboratory Diagnosis of Talasemia. In: International Journal of Laboratory Hematology. Pp: 32- 40. Carrucio L and Lerret NM. 2019. Fundamentals of Immunology. In Modern Blood Banking and Transfusion Practices 7th Ed. Philadelphia: F.A Davis Company. p: 45-76. Castillo B, Dasgupta A, Klein K, Tint H and Wahed A. 2018. Blood Bank Testing in Transfusion Medicine for Pathologists A Comprehensive Review for Board Preparation, Certification, and Clinical Practice. Editor: Ashdown M. United States: Elsevier. P: (4)51-68. Chapin J, Giardina P. 2018.’Talasemia Syndrome’ in Hoffman Hematology Basic Principles and Practice, 7th edition chapter 40. Elsevier sounders, pp : 546- 570. Dahlan MS. 2016. Hipotesis Korelatif. Dalam: Statistik untuk Kedokteran dan Kesehatan Seri I. Ed 6. P: 223. El-Beshlawy A, Salama AA, El-Masry MR, El Husseiny NM, Abdelhameed, AM. 2020. A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients. Scientific Reports, 10 (1), 21079. El Hasbani G, Musallam KM, Uthman I, Cappellini MD, & Taher AT. 2022. Thalassemia and autoimmune diseases: Absence of evidence or evidence of absence?. Blood Reviews, 52, 100874. Elkhalifa,AM, Abbas AM, Shalabi MG, Yassin N, Ahmed DZ, & Ahmed HAM. 2021. Red blood cell alloimmunization among multiple blood transfusions Sudanese patients. Blood Disord Transfus, 12, 475. Fateen T, Saqlain N, Mazhar N, Arshad S, Butt S, & Malik JZ. 2022. Alloimmunization and Autoimmunization in Multi-Transfused Thalassemic Patients: A Single Center Study. Pakistan Journal of Medical & Health Sciences, 16(10), 170-170. Fridawati V, Triyono T, Sukorini U. 2016. The Risk Factor of Alloantibody Formation in Talasemia Patients Receivinng Multiple Transfusion. Indonesian Journal of Clinical Pathology and Medical Laboratory 22(3), p: 241-245. 47 Friedberg RC and Johari VP. 2019. Autoimmune Hemolytic Anemia in Wintrobe’s Clinical Hematology. Fourteenth edition. Editor: Greer JP, Rodger GM, Arber DA, Means RT, List AF, Appelbaum FR et al., Philadelphia: Wolters Kluwer. P(31): 2420-82. Gaya ML, Rini EA, Arbi R, Izzah AZ. 2023. Hubungan Kadar Ferritin Serum Dengan Fungsi Tiroid Pada Anak Dengan Thalassemia β Mayor. Sari Pediatri. Vol 25. No. 1. P:1-5 Green REB, Slayten J and Rhees JR. 2019. The Antiglobulin Test in Modern Blood Bankong & Transfusion Practices. Editor: Harmening D. Seventh edition. Philadelphia: F.A Davis. P(5): 103-18. Harmany PP, Andarsini MR, Ugrasena IDG, Larasati MCS, & Cahyadi A. 2022. Risk factors for autoimmune hemolytic anemia in children with transfusion- dependent thalassemia at a tertiary referral hospital: A cross-sectional study. International Journal of Health Sciences, (IV), 691-701. Harmening DM, Forneris G, Tubby BJ. 2019. The ABO Blood Group System. Blood Groups and Serologic Testing in Modern Blood Banking & Transfusion Practices 7th Edition. Philadelphia: F.A Davis company. P:119- 48. Howard P. 2017. Blood Banking Reagents in Basic & Applied Concepts of Blood Banking and Transfusion Practices. Fourth Edition. St. Louis, Missouri: Elsevier. P(4): 99-147. Ido AAS, Oliveira MC. 2020. Main Erythrocyte Antigens Involved in the Alloimmunization Process. Open Science Journal 5(2). Jain A, Agnihotri A, Marwaha N & Sharma RR. 2016. Direct antiglobulin test positivity in multi-transfused thalassemics. Asian Journal of Transfusion Science. 10(2). p:161-3. Jeng M and Ellis N. 2019. Talasemia Syndromes: Quantitative Disorder of Globin Chain Syntesis, in Wintrobe’s Clinical Hematology.14th edition chapter 35. Lippincott & Williams, P : 2723-2877. Kaur D, Bains L, Kandwal M, & Parmar I. 2017. Erythrocyte alloimmunization and autoimmunization among blood donors and recipients visiting a tertiary care hospital. Journal of clinical and diagnostic research: JCDR, 11(3), EC12. Khaled MB, Ouederni M, Sahli N, Dhouib N, Abdelaziz AB, Rekaya S et al., 2019. Predictors of autoimmune hemolytic anemia in beta-talasemia patients with underlying red blood cells autoantibodies. Blood Cells, Molecules, and Diseases, 79, 102342. Kementerian Dalam Negeri (Kemendagri). 2021. Indonesia Miliki Bank Data 37,9 juta Golongan Darah diakses dari https://dukcapil.kemendagri.go.id/berita/baca/725/dirjen-dukcapil indonesia miliki-bank-data-379-juta-golongan-darah Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/1/2018 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Talasemia. Keohane ME. 2020. Talasemia in Rodak Hematology Clinical Priciples and Application, 6th edition chapter 25. Elsevier sounders, P: 424-44. Keramati MR, Sadeghian MH, & Zarmehri AM. 2019. Red Blood Cells Alloimmunization and Autoimmunization in Multi-transfused Thalassemia Patients in South of Iran. Iranian Journal of Pediatric Hematology & Oncology. Vol 9. No 1. P: 40-47 48 Kerkar AS, Bhagwat SN and Sharma JH. 2022. A Study of Clinical and Serological Correlation of Positive Direct Antiglobulin Test in Blood Bank at a Tertiary Care Center in Journal of Laboratory Physicians. p:18. Kumar Yadav B, Chaudhary RK, Shrivastava H & Elhence P. 2022. Prevalence of the Direct Antiglobulin Test and Its Clinical Impact on Multiply Transfused Talasemia Patients: A Prospective Study Conducted at a Tertiary Care Center in Northern India. Laboratory Medicine, lmac140. Lee YK, Kim H, Lee K, Park SH, Song SH, Seong M, Kim M, Han JY. 2019. ‘Recent Progress In Laboratory Diagnosis of Talasemia and Hemoglobinopathy: A Study by The Korean Red Blood Cell Disorder Working Party of the Korean Society of Hematology.’ In: Blood Res, (54), p 17-22. https:doi.org/10.5045/br.2019.54.1.17. Manchanda N. 2020. Red Blood Cell Morphology and Approach to Diagnosis in Talasemia’in Rodak Hematology Clinical Priciples and Application, 6th edition chapter 16. Elsevier sounders, pp:251-263 Matrix. 2002. Manual Instruction Matrixtm Direct Anti Globulin Test Card. Tulip Diagnostics (P) Ltd : India. Molina-Aguilar R, Gómez-Ruiz S, Vela-Ojeda J, Montiel-Cervantes LA, & Reyes- Maldonado E. 2020. Pathophysiology of alloimmunization. Transfusion Medicine and Hemotherapy, 47(2), P:152-159. Mulyantari NK, Yasa IWP. 2016. Antiglobulin Test (Coomb’sTest) dalam Laboratorium Pratransfusi Update. Editor: Atmaja J. Edisi Pertama. Udayana University Press: Bali. P: 104-26. Obaid JM, El-Nazar SYA, Ghanem AM, El-Hadidi AS, & Mersal BH. 2015. Red blood cells alloimmunization and autoimmunization among transfusion dependent beta thalassemia patients in Alexandria province, Egypt. Transfusion and Apheresis Science, 53(1), 52-57. Parker V and Tormey CA. 2017. The Direct Antiglobulin Test Indications, Interpretation, and Pitfalls in Archives of Pathology & Laboratory Medicine. Vol: 141. P: 305-10. Pessoni LL, Ferreira MA, Rodrigues da Silva JC, Correia de Alcantara K. 2018. Red Blood Cell Alloimmunization among Hospitalized Patients: Transfusion Reactions and Low Alloantibody Identification Rate, Hematology, Transfusion and Cell Therapy. Politou M, Komninaka V, Valsami S, Kapsimali V, Pouliakis A, Koutsouri, et al. 2020. The effect of transfusion on immune responses in thalassemia. Blood Cells, Molecules, and Diseases, 83, 102425. Rujito L. 2019. Penyebaran Talasemia in Talasemia: Genetik dasar dan Pengelolaan Terkini. 1st edition chapter 1, Universitas Jendral Sudirman,pp: 1-3. Sabath DE. 2017. Molecular Diagnosis of Talasemias and Hemoglobinopathies in ACLPS Critical Review, Washington: American Society for Clinical Pathology, p:6-15. 15. Sheth S, Swee L. 2021. Talasemia : A Disorder of Globin Synthesis, in Williams Hematologi. 10th edition chapter 49. Mc Graw-Hill Companies, pp : 785- 823. Stewart C, Davies P & Vyas H. 2020. A Practical Guide to Red Blood Cell Transfusion in Children. Paediatrics and Child Health, 30(3), 108- 113 Tatu T. 2020. Laboratory Diagnosis of ß-Talasemia and HbE, Thailand: Intech Open, p:1-40. 49 Tormey CA and Hedrickson JE. 2019. Transfusion-related Red Blood Cell Alloantibodies: Induction and Consequences. Blood 133(17). p: 1821-30. Walker PS & Harmening DM. 2019. Other Technologies and Automation. Blood Groups and Serologic Testing in Modern Blood Banking and Transfusion Practices. Seventh Edition. Philadelphia: F.A Davis company. P: 273- 285. William V, Rusmawatiningtyas D, Makrufardi F & Widjajanto PH. 2021. Comprehensive management of refractory autoimmune hemolytic anemia in pediatric beta-talasemia major patient: A case report. Annals of Medicine and Surgery, 70, 1028. Younas A, Ghias A, & Farhan S. 2019. Autoimmunization And Alloimmunization In Transfusion Dependant Thalassemia Major Patients: Study On 300 Patients. HemaSphere, 3(S1), 734-735.
local.eprints.dirdisk0/00/46/44/86
local.eprints.division02
local.eprints.id464486
local.eprints.typethesis/masters
local.eprints.urihttp://scholar.unand.ac.id/464486/
local.fakultasFakultas Kedokteran
local.identifier.nim1950307204
local.thesis.levelTesis

Files

Collections